Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer

被引:25
作者
Mazouni, Chafika [1 ]
Koual, Meriem [1 ]
De Leeuw, Frederic [2 ,3 ]
Conversano, Angelica [1 ]
Leymarie, Nicolas [1 ]
Rimareix, Francoise [1 ]
Alkhashnam, Heba [1 ]
Laplace-Builhe, Corinne [2 ,3 ]
Abbaci, Muriel [2 ,3 ]
机构
[1] Univ Paris Saclay, Gustave Roussy, Dept Surg, Div Breast & Plast Surg, Villejuif, France
[2] Univ Paris Saclay, Gustave Roussy, Imaging & Cytometry Platform, UMS 23 3655, Villejuif, France
[3] Univ Paris Saclay, Univ Paris Sud, CNRS, UMR 8081,IR4M, Orsay, France
关键词
breast cancer; indocyanine green; sentinel lymph node; technetium; false negative; INDOCYANINE GREEN FLUORESCENCE; GASTRIC-CANCER; BIOPSY;
D O I
10.1111/tbj.13123
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We compared the performance of near-infrared imaging using indocyanine green (ICG) with the radioisotope (ISO) method to detect sentinel lymph nodes (SLNs) in breast cancer, to analyze predictive factors for negative ICG identification. The study included 122 patients who underwent sentinel lymph node biopsy (SLNB) using the combined ISO and ICG technique for primary breast cancer. We assessed the putative association between pathologic/clinical variables and ICG failure to detect SLNs. The ISO identification rate was 96.7% and ICG identification 81.9%. Overweight patients or presence of macrometastasis in SLNB were associated with the risk of ICG failing to detect SLNs (P = 0.02).
引用
收藏
页码:1006 / 1009
页数:4
相关论文
共 17 条
[1]   Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review [J].
Ahmed, Muneer ;
Purushotham, Arnie D. ;
Douek, Michael .
LANCET ONCOLOGY, 2014, 15 (08) :E351-E362
[2]   Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green [J].
Aoyama, Kei ;
Kamio, Takako ;
Ohchi, Tetsuya ;
Nishizawa, Masako ;
Kameoka, Shingo .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2011, 9
[3]   Anaphylactic response to blue dye during sentinel lymph node biopsy [J].
Bezu, Corinne ;
Coutant, Charles ;
Salengro, Anne ;
Darai, Emile ;
Rouzier, Roman ;
Uzan, Serge .
SURGICAL ONCOLOGY-OXFORD, 2011, 20 (01) :E55-E59
[4]   Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study [J].
Coufal, Oldrich ;
Fait, Vuk .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
[5]   The Role of Blue Dye in Sentinel Node Detection for Breast Cancer: A Retrospective Study of 203 Patients [J].
Garbay, Jean-Remi ;
Skalli-Chrisostome, Dounia ;
Leymarie, Nicolas ;
Sarfati, Benjamin ;
Rimareix, Francoise ;
Mazouni, Chafika .
BREAST CARE, 2016, 11 (02) :128-132
[6]   ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial [J].
Grischke, E. -M. ;
Roehm, C. ;
Hahn, M. ;
Helms, G. ;
Brucker, S. ;
Wallwiener, D. .
GEBURTSHILFE UND FRAUENHEILKUNDE, 2015, 75 (09) :935-940
[7]   Recent advances in sentinel node navigation for gastric cancer: A paradigm shift of surgical management [J].
Kitagawa, Y ;
Fujii, H ;
Kumai, K ;
Kubota, T ;
Otani, Y ;
Saikawa, Y ;
Yoshida, M ;
Kubo, A ;
Kitajima, M .
JOURNAL OF SURGICAL ONCOLOGY, 2005, 90 (03) :147-151
[8]   Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer [J].
Kitai T. ;
Inomoto T. ;
Miwa M. ;
Shikayama T. .
Breast Cancer, 2005, 12 (3) :211-215
[9]   The sentinel node in breast cancer - A multicenter validation study [J].
Krag, D ;
Weaver, D ;
Ashikaga, T ;
Moffat, F ;
Klimberg, VS ;
Shriver, C ;
Feldman, S ;
Kusminsky, R ;
Gadd, M ;
Kuhn, J ;
Harlow, S ;
Beitsch, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :941-946
[10]   Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update [J].
Lyman, Gary H. ;
Somerfield, Mark R. ;
Bosserman, Linda D. ;
Perkins, Cheryl L. ;
Weaver, Donald L. ;
Giuliano, Armando E. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05) :561-+